Cutaneous T-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Cutaneous T-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-27Clinical Trial Update: Combating Cancer-Related Fatigue: A Personalized Supportive Care Program [NA]
This clinical trial update reports a UNC Lineberger Comprehensive Cancer Center study recruiting participants for a personalized supportive …
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: CD5 CAR T-Cell Therapy for r/r T-cell Lymphomas [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating CD5-targeted CAR T-cell therapy for relapsed/refractory T-cell lymphomas is currently recruiting in Be…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Skin Barrier and Microbiome of CTCL Patients
The trial update reports on a study evaluating skin barrier function and the skin microbiome in patients with cutaneous T-cell lymphoma (CTC…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies [Phase 1]
Phase 1 trial evaluating a combination of romidepsin, CC-486 (oral azacitidine), dexamethasone, and lenalidomide (RAdR) for relapsed/refract…
-
CLINICAL_TRIALS withdrawal · 2025-06-12Clinical Trial Update: Triamcinolone Acetonide Injections in Primary Cutaneous Lymphoma Plaques With a Novel Needle-free Drug-delivery System. [NA]
A clinical trial evaluating Triamcinolone acetonide injections with a novel needle-free delivery system for primary cutaneous lymphoma plaqu…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-26Clinical Trial Update: Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast Cancer [Phase 1]
Phase 1 clinical trial evaluating direct tumor microinjection and FDG-PET to test drug sensitivity in patients with relapsed or refractory n…
-
CLINICAL_TRIALS research · 2025-05-13Clinical Trial Update: CD7 CAR T-Cell Therapy for r/r T-cell Lymphomas [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating CD7-directed CAR T-cell therapy for relapsed/refractory T-cell lymphomas (including PTCL and CTC…
-
CLINICAL_TRIALS withdrawal · 2025-05-02Clinical Trial Update: Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma [Phase 1]
A Phase 1 trial evaluating reduced-intensity conditioning before a partially matched donor stem cell transplant for advanced cutaneous T-cel…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Novel Flow-cytometry Approaches to Improve the Detection of Tumor Cells in CTCL
A clinical trial update describes novel flow-cytometry approaches for enhanced detection of tumor cells in cutaneous T-cell lymphoma (CTCL).…
-
CLINICAL_TRIALS research · 2025-04-06Clinical Trial Update: A Clinical Study of CHT101 in CD70-Positive Relapsed or Refractory Hematological Malignancies [Phase 1]
A Phase 1 clinical study evaluating the CD70-targeted agent CHT101 in relapsed or refractory hematologic malignancies is currently recruitin…
-
CLINICAL_TRIALS trial_result · 2025-04-04Clinical Trial Update: A Study to Assess the Feasibility of Romidepsin Combined With Brentuximab Vedotin in Cutaneous T-cell Lymphoma [Phase 1]
A Phase 1 study evaluating the feasibility of combining romidepsin with brentuximab vedotin in cutaneous T-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2025-03-20Clinical Trial Update: Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma [Phase 1]
Phase 1 trial of Yttrium-90 labeled basiliximab with combination chemotherapy before stem cell transplant for mature T-cell and NK-cell non-…
-
CLINICAL_TRIALS trial_result · 2025-03-19Clinical Trial Update: Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors [Phase 1]
Phase 1 trial of KT-333 in adults with refractory lymphomas and solid tumors reports safety, pharmacokinetics, pharmacodynamics, and prelimi…
-
CLINICAL_TRIALS research · 2025-02-24Clinical Trial Update: A Clinical Trial of BP1002 in Patients With Advanced Lymphoid Malignancies [Phase 1]
Phase 1 clinical trial update for BP1002 in advanced lymphoid malignancies across several B-cell and T-cell lymphomas; trial status is activ…
-
CLINICAL_TRIALS research · 2024-12-09Clinical Trial Update: A Trial Assessing the Effect of Pembrolizumab Combined with Radiotherapy in Patients with Relapsed, Refractory, Specified Stages of Cutaneous T-cell Lymphoma (CTCL) Mycosis Fungoides (MF)/Sezary Syndrome (SS) [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab in combination with radiotherapy for relapsed, refractory cutaneous T-cell lymphoma, speci…
-
CLINICAL_TRIALS trial_result · 2024-12-04Clinical Trial Update: A Study in Adults With Cutaneous T-cell Lymphoma (CTCL) Retreated With Brentuximab Vedotin
The study evaluating retreatment with Brentuximab Vedotin in adults with cutaneous T-cell lymphoma has completed. The clinical trial update …
-
CLINICAL_TRIALS research · 2024-11-21Clinical Trial Update: MORPHEE : Mechanisms of Cell Death Induced by Extracorporeal Photochemotherapy [NA]
ClinicalTrials.gov entry MORPHEE investigates mechanisms of cell death induced by extracorporeal photochemotherapy, with conditions includin…
-
CLINICAL_TRIALS trial_result · 2024-11-13Clinical Trial Update: A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma [Phase 3]
A Phase 3 trial evaluating E7777 for persistent and recurrent cutaneous T-cell lymphoma has completed. Results from the study have been post…
-
CLINICAL_TRIALS research · 2024-11-08Clinical Trial Update: IPH4102 Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma [Phase 2]
A Phase 2 clinical trial of IPH4102 (lacutamab) alone or in combination with chemotherapy is evaluating advanced T-cell lymphomas, including…
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Pilot Study to Characterize the Microbiome in Cutaneous T Cell Lymphoma Skin Lesions Before and After Use of CLn® Skin Care Body Wash
Pilot study to characterize the microbiome in Cutaneous T Cell Lymphoma skin lesions before and after using CLn Skin Care Body Wash; trial s…
-
CLINICAL_TRIALS research · 2024-10-21Clinical Trial Update: Evaluation of the KIR3DL2 Marker in Flow Cytometry for Sézary Syndrome Diagnosis, Therapeutic Response and Residual Disease: a Prospective and Multicenter Study
Prospective multicenter study evaluating flow cytometry detection of the KIR3DL2 marker for diagnosing Sézary syndrome, assessing therapeuti…
-
CLINICAL_TRIALS research · 2024-10-08Clinical Trial Update: A Pilot of a Microdevice For In Situ Candidate Drug Screening in Cutaneous Lesions of T-Cell Lymphoma [NA]
This clinical trial update describes a pilot study using a microdevice to screen candidate drugs in cutaneous lesions from patients with cut…
-
CLINICAL_TRIALS trial_result · 2024-09-20Clinical Trial Update: Outcomes of Cutaneous T-Cell Lymphoma and Graft-Versus-Host Disease With Extracorporeal Photopheresis Treatment
This completed clinical trial (NCT01460914) reports outcomes of extracorporeal photopheresis treatment for cutaneous T-cell lymphoma and gra…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Spanish Medical Record Review of Adults With Relapsed or Refractory CD30+ Malignancies When Re-treated With Brentuximab-vedotin
A completed study update based on a Spanish medical-record review of adults with relapsed or refractory CD30+ malignancies who were re-treat…
-
FDA approval · 2024-09-06FDA Approved: BEXAROTENE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original ANDA for a generic Bexarotene product for the treatment of cutaneous T-cell lymphoma (CTCL). T…